Effectiveness of a clinical decision support algorithm (ePOCT plus ) in improving quality of care for sick children in primary health facilities in Tanzania (DYNAMIC project): results from a cluster randomized trial

被引：0

|

作者：

Enos, Caroline ^{[1
]}

Kavishe, Godfrey A. ^{[1
]}

Kulinkina, Alexandra, V ^{[2
]}

Renggli, Sabine ^{[3
]}

Mangu, Chacha D. ^{[1
]}

Luwanda, Lameck ^{[3
]}

Agrea, Peter ^{[1
]}

Mhagama, Humphrey ^{[1
]}

Joram, Margaret ^{[3
]}

Mtebene, Ibrahim ^{[3
]}

Ashery, Geofrey Isdory ^{[3
]}

Le Pogam, Marie-Annick ^{[4
]}

Masanja, Honorati ^{[3
]}

Ntinginya, Nyanda E. ^{[1
]}

D'Acremont, Valerie ^{[4
]}

Tan, Rainer ^{[4
]}

机构：

[1] Natl Inst Med Res, Mbeya Med Res Ctr, Mbeya, Tanzania

[2] Swiss Trop & Publ Hlth Inst, Allschwil, Switzerland

[3] Ifakara Hlth Inst, Dar Es Salaam, Tanzania

[4] Univ Lausanne, Ctr Primary Care & Publ Hlth, Unisante, Lausanne, Switzerland

来源：

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2025年 / 152卷

关键词：

D O I：

10.1016/j.ijid.2024.107409

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

收藏

页数：2

相关论文

共 23 条

[21] Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial (vol 8, pg 87, 2015)
不详
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (09):
[22] Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer
Moinpour, Carol M.
Donaldson, Gary W.
Liepa, Astra M.
Melemed, Allen S.
O'Shaughnessy, Joyce
Albain, Kathy S.
QUALITY OF LIFE RESEARCH, 2012, 21 (05) : 765 - 775
[23] Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer
Carol M. Moinpour
Gary W. Donaldson
Astra M. Liepa
Allen S. Melemed
Joyce O’Shaughnessy
Kathy S. Albain
Quality of Life Research, 2012, 21 : 765 - 775